sk&f 83959 has been researched along with diazepam in 1 studies
| Studies (sk&f 83959) | Trials (sk&f 83959) | Recent Studies (post-2010) (sk&f 83959) | Studies (diazepam) | Trials (diazepam) | Recent Studies (post-2010) (diazepam) |
|---|---|---|---|---|---|
| 94 | 0 | 46 | 18,377 | 2,329 | 1,790 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, M; Kanematsu, T; Kinsella, A; Kobayashi, M; Koshikawa, N; Song, L; Tomiyama, K; Waddington, JL | 1 |
1 other study(ies) available for sk&f 83959 and diazepam
| Article | Year |
|---|---|
Orofacial movements in phospholipase C-related catalytically inactive protein-1/2 double knockout mice: Effect of the GABAergic agent diazepam and the D(1) dopamine receptor agonist SKF 83959.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Carrier Proteins; Diazepam; Dopamine Agonists; Dose-Response Relationship, Drug; Face; Female; GABA Modulators; Head Movements; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Mouth; Movement; Receptors, Dopamine D1; Vibrissae | 2010 |